We are announcing a new collaboration with Atea Pharmaceuticals to develop a potential oral medication to treat #COVID19 patients also outside the hospital setting.
New challenges call for new solutions. Cloud-based clinical decision support software allows #oncology care teams to continue their work remotely, so #patients don’t have to wait for answers.
«A diversity of thinking and mutual trust» are fundamental for a company to excel, particularly in times of crisis, says Roche Chairman Christoph Franz. Watch the entire interview with @IMD_Bschool Professor Didier Cossin 👉
Pravene Nath, MD, our Global Head for Digital Health Strategy, shares his thoughts on how #COVID19 has exemplified the need to bring the entire healthcare system up to date in order for #digitalhealth tools to have the greatest impact. Read more:
During #WorldDrugSafetyCongress, our Global Head of Safety shares how every therapy comes with a benefit/ risk ratio, and while maximizing the benefit is what comes to mind first when talking about medicines, our teams are working tirelessly to decrease the risk of side effects.
We are thrilled to bring together the bright scientists from Roche, @Spark_Tx and @Dyno_Tx to develop novel #gene therapies together. #RocheInnovation #innovation #ai
New collaboration to foster #innovation with @Dyno_Tx to leverage their #AI-powered approach to develop novel #gene therapies #RocheInnovation
The Covid-19 pandemic has exposed the need for resilience in our health care systems. Digital health is one key solution, but we must learn from the success and failures to date
We are exploring the use of gene therapy to improve the lives of patients faced with #EyeDisease. Find out more about our innovative approach to reduce #VisionLoss here:
"It will be a painful process to shift to a more environmentally friendly economy. But that's essentially what we need," says Steve, a chemist turned technologist harnessing elements of #sustainability in his approach to #leadership and life 👉